Related references
Note: Only part of the references are listed.Single-agent lenalidomide induces complete remission of acute myeloid leukemia in patients with isolated trisomy 13
Todd A. Fehniger et al.
BLOOD (2009)
Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4(+)Foxp3(+) T cells
M. C. Minnema et al.
LEUKEMIA (2009)
Hematologic and cytogenetic response to lenalidomide in de novo acute myeloid leukemia with chromosome 5q deletion
Maria J. Peñarrubia et al.
LEUKEMIA RESEARCH (2009)
Treatment of deletion 5q acute myeloid leukemia with lenalidomide
J. E. Lancet et al.
LEUKEMIA (2007)
Hematologic and cytogenetic response to lenalidomide monotherapy in acute myeloid leukemia arising from JAK2V617F positive, del(5) (q13q33) myelodysplastic syndrome
R. A. Mesa et al.
LEUKEMIA (2006)
Efficacy of lenalidomide in myelodysplastic syndromes
A List et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myelome (IFM) and the Societe Francaise de Greffe de Moelle et Therapie Cellulaire (SFGM-TC)
M Mohty et al.
BONE MARROW TRANSPLANTATION (2005)